Nathen Fuentes

Insider Reports History

Entity
Individual
Location
C/O Telomir Pharmaceuticals, Inc., 900 West Platt Street, Suite 200, Tampa, FL
Signature
/s/ Nathen Fuentes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathen Fuentes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Telomir Pharmaceuticals, Inc. Chief Financial Officer Common Stock 101K $627K $6.20 Feb 8, 2024 Direct
RENOVARO INC. Chief Financial Officer Option to purchase shares of common stock 250K Jan 21, 2025 Direct

Insider Reports Filed by Nathen Fuentes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RENB RENOVARO INC. Jan 21, 2025 1 $0 4 Feb 25, 2025 Chief Financial Officer
RENB RENOVARO INC. Jan 6, 2025 0 $0 3 Jan 13, 2025 Chief Financial Officer
TELO Telomir Pharmaceuticals, Inc. Feb 8, 2024 0 $0 3 Feb 8, 2024 Chief Financial Officer